Doliver Advisors’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.07M | Buy |
2,699
+503
| +23% | +$220K | 0.24% | 66 |
|
|
2026
Q1 | $1.01M | Sell |
2,196
-165
| -7% | -$83.5K | 0.23% | 70 |
|
|
2025
Q4 | $1.34M | Buy |
2,361
+171
| +8% | +$91K | 0.33% | 57 |
|
|
2025
Q3 | $979K | Buy |
2,190
+33
| +2% | +$15.8K | 0.25% | 75 |
|
|
2025
Q2 | $1.17M | Sell |
2,157
-1,153
| -35% | -$603K | 0.32% | 55 |
|
|
2025
Q1 | $1.64M | Sell |
3,310
-166
| -5% | -$91.8K | 0.46% | 33 |
|
|
2024
Q4 | $1.81M | Sell |
3,476
-58
| -2% | -$30.2K | 0.5% | 31 |
|
|
2024
Q3 | $1.74M | Sell |
3,534
-261
| -7% | -$122K | 0.48% | 33 |
|
|
2024
Q2 | $1.69M | Sell |
3,795
-37
| -1% | -$14.7K | 0.47% | 32 |
|
|
2024
Q1 | $1.53M | Sell |
3,832
-476
| -11% | -$180K | 0.43% | 37 |
|
|
2023
Q4 | $1.45M | Buy |
4,308
+30
| +0.7% | +$8.94K | 0.45% | 42 |
|
|
2023
Q3 | $1.25M | Buy |
4,278
+80
| +2% | +$25K | 0.38% | 44 |
|
|
2023
Q2 | $1.44M | Buy |
4,198
+656
| +19% | +$198K | 0.44% | 36 |
|
|
2023
Q1 | $905K | Sell |
3,542
-615
| -15% | -$152K | 0.28% | 59 |
|
|
2022
Q4 | $1.1M | Sell |
4,157
-29
| -0.7% | -$7.07K | 0.36% | 45 |
|
|
2022
Q3 | $785K | Sell |
4,186
-2,719
| -39% | -$584K | 0.29% | 58 |
|
|
2022
Q2 | $1.39M | Buy |
6,905
+39
| +0.6% | +$9.15K | 0.49% | 32 |
|
|
2022
Q1 | $2.07M | Sell |
6,866
-155
| -2% | -$45.3K | 0.65% | 24 |
|
|
2021
Q4 | $2.01M | Sell |
7,021
-857
| -11% | -$295K | 0.63% | 22 |
|
|
2021
Q3 | $2.61M | Sell |
7,878
-1,431
| -15% | -$481K | 0.88% | 14 |
|
|
2021
Q2 | $2.85M | Sell |
9,309
-279
| -3% | -$78.3K | 0.95% | 15 |
|
|
2021
Q1 | $2.36M | Buy |
9,588
+516
| +6% | +$130K | 0.88% | 17 |
|
|
2020
Q4 | $2.47M | Buy |
9,072
+555
| +7% | +$138K | 1.09% | 13 |
|
|
2020
Q3 | $2.01M | Sell |
8,517
-6,453
| -43% | -$1.45M | 1.02% | 12 |
|
|
2020
Q2 | $2.84M | Buy |
14,970
+510
| +4% | +$91.4K | 1.27% | 13 |
|
|
2020
Q1 | $2.49M | Sell |
14,460
-831
| -5% | -$152K | 1.23% | 14 |
|
|
2019
Q4 | $3.01M | Buy |
15,291
+4,038
| +36% | +$756K | 1.19% | 9 |
|
|
2019
Q3 | $1.98M | Buy |
11,253
+699
| +7% | +$121K | 0.8% | 16 |
|
|
2019
Q2 | $1.84M | Buy |
10,554
+2,265
| +27% | +$388K | 0.73% | 17 |
|
|
2019
Q1 | $1.58M | Buy |
8,289
+2,685
| +48% | +$477K | 0.64% | 18 |
|
|
2018
Q4 | $895K | Buy |
+5,604
| New | +$950K | 0.44% | 24 |
|
Other funds holding ISRG
Doliver Advisors's ISRG Position: Q2 2026 in Review
Doliver Advisors increased its Intuitive Surgical (ISRG) stake by 23% in Q2 2026, buying an estimated $220K and bringing the position to 2,699 shares worth $1.07M. The position accounts for 0.24% of the portfolio, ranked #66.
Doliver Advisors first reported a position in ISRG in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.01M in Q4 2019. 2,254 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Doliver Advisors held 2,699 shares of Intuitive Surgical worth $1.07M as of Q2 2026.
- Doliver Advisors bought 503 Intuitive Surgical shares in Q2 2026, an estimated $220K.
- Intuitive Surgical made up 0.24% of Doliver Advisors's portfolio in Q2 2026, its #66 holding.
- Doliver Advisors first reported a position in Intuitive Surgical in Q4 2018 and has held it in 31 quarters since.
- Doliver Advisors's Intuitive Surgical position peaked at $3.01M in Q4 2019.
- 2,254 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Doliver Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.